BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8711699)

  • 1. [Tamoxifen and endometrial cancer. A case report].
    Orbo A; Lindal S; Mortensen E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(16):1877-8. PubMed ID: 8711699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
    Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
    Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].
    Menada MV; Corticelli A; Giannesi A; Nicoletti L; Podesta M; Rissone R; Fulcheri E
    Minerva Ginecol; 2000 Dec; 52(12):521-6. PubMed ID: 11310150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma and tamoxifen: clearing up a controversy.
    Jordan VC; Assikis VJ
    Clin Cancer Res; 1995 May; 1(5):467-72. PubMed ID: 9816005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
    Swerdlow AJ; Jones ME;
    J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
    Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
    Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endolymphatic stromal myosis associated with tamoxifen use.
    Eddy GL; Mazur MT
    Gynecol Oncol; 1997 Feb; 64(2):262-4. PubMed ID: 9038273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: A case report and review of the literature.
    Schlesinger C; Silverberg SG
    Gynecol Oncol; 1999 May; 73(2):305-11. PubMed ID: 10329051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraepithelial G3 adenocarcinoma of the endometrium after tamoxifen treatment.
    Marchesoni D; Driul L; Mozzanega B; Nardelli GB; Parenti A
    Arch Gynecol Obstet; 2005 Jan; 271(1):62-5. PubMed ID: 15290168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial cancer and recurrence with hormonal manipulation.
    Ghosh P; Fawzi H
    J Obstet Gynaecol; 2004 Feb; 24(2):192-3. PubMed ID: 14766474
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endometrial cancers arising in polyps associated with tamoxifen use].
    Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
    Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature.
    Treilleux T; Mignotte H; Clement-Chassagne C; Guastalla P; Bailly C
    Eur J Surg Oncol; 1999 Oct; 25(5):477-82. PubMed ID: 10527595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen in cancer therapy: minireview.
    Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
    Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen, screening and new oestrogen receptor modulators.
    Neven P; Vergote I
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):365-80. PubMed ID: 11476559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.